The Clinical Trial to Evaluate the Pharmacokinetics, Safety and Tolerability of ZL-2306 (Niraparib) in Patients With Ovarian Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Clinical Trials Related to Ovarian Cancer
Related studies linked through entity extraction aliases.
A Phase I/Ib Study of NZV930 Alone and in Combination With PDR001 and /or NIR178 in Patients With Advanced Malignancies.
- Status
- TERMINATED
- Phase
- PHASE1
Clinical Study of Apatinib in the Treatment of Advanced Ovarian Cancer After the Failure of Standard Chemotherapy
- Status
- UNKNOWN
- Phase
- PHASE2
Diaphragmatic Resection And Gynecological Ovarian Neoplasm
- Status
- COMPLETED
- Phase
- PHASE4
HIPEC After Initial CRS in Patients Who Have Received NACT
- Status
- UNKNOWN
- Phase
- PHASE1
Study on MK-3475 Plus Chemotherapy Versus Chemotherapy Alone in Recurrent, Platinum-resistant Ovarian Cancer
- Status
- UNKNOWN
- Phase
- PHASE2
The DETECT Study: Discovery and Evaluation of Testing for Endometrial and Ovarian Cancer in Tampons
- Status
- RECRUITING
- Phase
- N/A
A Safety and Tolerability Study of INCAGN02385 in Select Advanced Malignancies
- Status
- COMPLETED
- Phase
- PHASE1
Pilot Study of Rosuvastatin and Enoxaparin Thromboprophylaxis Following Ovarian Cancer Surgery (O-STAT Study)
- Status
- COMPLETED
- Phase
- PHASE2
Molecular Imaging and Spectroscopy With Stable Isotopes in Oncology and Neurology
- Status
- UNKNOWN
- Phase
- N/A
Maintenance Treatment With BGB-290 Versus Placebo in Participants With Platinum-sensitive Recurrent Ovarian Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Restrictive or Individualized Goal-Directed Fluid Replacement Strategy in Ovarian Cancer Cytoreductive Surgery
- Status
- COMPLETED
- Phase
- NA
Circulating Tumor DNA Exposure in Peripheral Blood
- Status
- UNKNOWN
- Phase
- N/A
FPA150 in Patients With Advanced Solid Tumors
- Status
- TERMINATED
- Phase
- EARLY_PHASE1
A Study of Fluzoparib（SHR-3162）in BRCA1/2-mutant Relapsed Ovarian Cancer
- Status
- COMPLETED
- Phase
- PHASE1
A Study of IMP4297 in Patients With Advanced Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
The Safety and Pharmacokinetics of IMP4297 in Patients With Advanced Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Lynparza Ovarian Cancer Clinical Experience Investigation (All Case Investigation)
- Status
- COMPLETED
- Phase
- N/A
BR55 in Characterization of Ovarian Lesions
- Status
- TERMINATED
- Phase
- PHASE2
Study to Evaluate Safety, PK, PD, Immunogenicity & Antitumor Activity of MSC-1 in Patients With Adv Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1